Abbott gains RX catheter patent extension
This article was originally published in The Gray Sheet
Executive Summary
U.S. Patent and Trademark Office grants Abbott a one-year interim extension Oct. 14 for its coveted rapid-exchange catheter patent, set to expire Oct. 29. Abbott had filed for a nearly three-year extension on July 25 for the patent, which was originally granted to Dr. Paul Yock in 1995 (1"The Gray Sheet" Sept. 1, 2008, p. 3). Competitors AngioScore and Medtronic oppose the extension. PTO believes the patent qualifies for full extension, but FDA has not yet completed its portion of the patent extension review. Abbott's attorneys met with PTO on Sept. 3 to discuss products that utilize the Yock patent; prior litigation involving the patent, including a Medtronic lawsuit and motion to lift an injunction barring Medtronic from using RX catheters; and an Aug. 19 citizen's petition filed by AngioScore opposing the extension. The physician-preferred RX catheter delivery system is particularly important to Medtronic's stent business, the firm says
You may also be interested in...
Court lifts Medtronic’s RX catheter injunction
A May 2000 injunction that has barred Medtronic from manufacturing or marketing rapid-exchange catheters will end Oct. 29, the date on which Abbott's RX patent was originally supposed to expire, the U.S. District Court for the Northern District of California 1ruled Oct. 21. The court concluded that Abbott would not suffer any material damage, and that lifting the ban suits the public interest and the spirit of the Patent Term Restoration Act. The ruling follows a one-year interim patent extension granted to Abbott on Oct. 14 by the U.S. Patent and Trademark Office (2"The Gray Sheet" Oct. 20, 2008, In Brief). Medtronic says it will announce its commercial plans after Oct. 29. The firm may choose to launch despite the extension and risk modest infringement damages if a full extension is granted, according to Morgan Stanley analyst David Lewis
Medtronic, AngioScore Challenge Abbott’s Attempt To Extend Catheter Patent
Device firms Medtronic and AngioScore are fighting an effort by Abbott to extend the life of its valuable "rapid-exchange" catheter patent, set to expire Oct. 29
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”